Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats
Journal of Basic and Clinical Physiology and Pharmacology · 01.06.2016 · 27 (4) · 411-424
DOI: 10.1515/jbcpp-2015-0105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, online erschienen am 12.03.2016. Verfasst von Enas Ahmed Hamed und 5 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Chemokines have been recently recognized to play a role in chronic pain syndromes’ pathophysiology. This study investigated the role of monocyte chemoattractant protein-1 (MCP-1), stromal cell derived factor-1 (SDF-1), and retinoic acid (RA) as targets for the therapeutic approach of neuropathic pain.
Methods
A chronic constriction injury (CCI) model of neuropathic pain by unilateral ligation of left sciatic nerve was performed in adult female Wistar rats. The effects of doxycycline (Dox, 50 mg/kg/day i.p. for 7 days), single dose of bicyclam (5 mg/kg i.p.), RA (15 mg/kg/day i.p. for 7 days), and their combination(s) on behavioral tests of nociception (Von Frey filaments; paw pressure test) on days 0, 1, 3, 5, and 7 of operation were studied. Serum concentrations of MCP-1 and SDF-1 were measured by ELISA. Histological examination of the sciatic nerve was investigated.
Results
CCI of sciatic nerve significantly induced mechanical allodynia and hyperalgesia and an increase of MCP-1 and SDF-1 serum levels. Dox-treated groups (Dox, Dox+bicyclam, Dox+RA, Dox+bicyclam+RA) and bicyclam-treated groups (bicyclam, Dox+bicyclam, bicyclam+RA, Dox+bicyclam+RA) attenuated CCI-induced behavioral and biochemical changes. RA inhibited CCI-induced mechanical hyperalgesia but produced a time-dependent reversal of allodynia. Histological findings showed degenerative changes of sciatic nerve after CCI that were partially recovered in Dox-treated groups.
Conclusions
These findings demonstrate an association between serum MCP-1 and SDF-1 concentrations and behavioral manifestations of neuropathic pain. RA administration decreased neuropathic pain (antihyperalgesic effect) but did not cause any improvement in sciatic nerve tissues, either alone or in combination with chemokine antagonists. Thus, chemokines may serve as potential targets for drug development in neuropathic pain treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Hamed, E. A., Mohamed Farghaly, H. S., Abdel Mola, A. F., Fahmi, M. K., Makhlouf, M. M., & Balfas, M. A. (2016). Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats. Journal of Basic and Clinical Physiology and Pharmacology, 27(4), 411-424. https://doi.org/10.1515/jbcpp-2015-0105
Vancouver
Hamed EA, Mohamed Farghaly HS, Abdel Mola AF, Fahmi MK, Makhlouf MM, Balfas MA. Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats. Journal of Basic and Clinical Physiology and Pharmacology. 2016;27(4):411-424. doi:10.1515/jbcpp-2015-0105
BibTeX
@article{Hamed2016,
author = {Hamed, Enas Ahmed and Mohamed Farghaly, Hanan Sayed and Abdel Mola, Asmaa Fathey and Fahmi, Minerva Kamal and Makhlouf, Madiha Mohammed and Balfas, Mohamed Abdullah},
title = {Role of monocyte chemoattractant protein-1, stromal derived factor-1 and retinoic acid in pathophysiology of neuropathic pain in rats},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2016},
volume = {27},
number = {4},
pages = {411--424},
doi = {10.1515/jbcpp-2015-0105}
}
EUVIMED